154 related articles for article (PubMed ID: 14745558)
21. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers.
Masuda A; Maeno K; Nakagawa T; Saito H; Takahashi T
Am J Pathol; 2003 Sep; 163(3):1109-16. PubMed ID: 12937152
[TBL] [Abstract][Full Text] [Related]
22. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
[TBL] [Abstract][Full Text] [Related]
23. Timing of antitubulin therapy: does it matter?
Livingston RB
Cancer Invest; 2000; 18(8):804-5. PubMed ID: 11107452
[No Abstract] [Full Text] [Related]
24. Gefitinib enhances cytotoxicities of antimicrotubule agents in non-small-cell lung cancer cells exhibiting no sensitizing epidermal growth factor receptor mutation.
Tsai CM; Chiu CH; Chang KT; Chen JT; Lai CL; Chen YM; Hsiao SY
J Thorac Oncol; 2012 Aug; 7(8):1218-27. PubMed ID: 22659964
[TBL] [Abstract][Full Text] [Related]
25. Effect of vinorelbine on the growth of human myeloma cell lines in vitro.
Ochiai N; Shimazaki C; Inaba T; Fuchida S; Okano A; Hatsuse M; Hirai H; Ashihara E; Fujita N; Nakagawa M
Leuk Res; 2002 Aug; 26(8):731-8. PubMed ID: 12191568
[TBL] [Abstract][Full Text] [Related]
26. A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC.
Dean EJ; Ward T; Pinilla C; Houghten R; Welsh K; Makin G; Ranson M; Dive C
Br J Cancer; 2010 Jan; 102(1):97-103. PubMed ID: 19904270
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
28. [Modification of the response to paclitaxel of human differentiated colon cancer line after long-term treatment at very low dose].
Carles G; Braguer D; Rognoni JB; Roccabianca M; Marvaldi J; Briand C
Bull Cancer; 1996 Feb; 83(2):135-8. PubMed ID: 8652907
[TBL] [Abstract][Full Text] [Related]
29. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines.
Gu WZ; Chen Z; Tahir SK; Rosenberg SH; Ng SC
Anticancer Drugs; 1999 Nov; 10(10):895-901. PubMed ID: 10630357
[TBL] [Abstract][Full Text] [Related]
31. Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.
Thurmond LM; Stimmel JB; Ingram AC; Ryan CH; Murray DM; Eberwein DJ; Witherspoon SM; Knick VC
Cancer Immunol Immunother; 2003 Jul; 52(7):429-37. PubMed ID: 12695858
[TBL] [Abstract][Full Text] [Related]
32. BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.
Quinn JE; Kennedy RD; Mullan PB; Gilmore PM; Carty M; Johnston PG; Harkin DP
Cancer Res; 2003 Oct; 63(19):6221-8. PubMed ID: 14559807
[TBL] [Abstract][Full Text] [Related]
33. Synergistic interaction between topotecan and microtubule-interfering agents.
Bahadori HR; Green MR; Catapano CV
Cancer Chemother Pharmacol; 2001 Sep; 48(3):188-96. PubMed ID: 11592339
[TBL] [Abstract][Full Text] [Related]
34. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines.
Photiou A; Shah P; Leong LK; Moss J; Retsas S
Eur J Cancer; 1997 Mar; 33(3):463-70. PubMed ID: 9155533
[TBL] [Abstract][Full Text] [Related]
35. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
Chang AY; Garrow GC
Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
[TBL] [Abstract][Full Text] [Related]
36. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines.
Aoe K; Kiura K; Ueoka H; Tabata M; Matsumura T; Chikamori M; Matsushita A; Kohara H; Harada M
Anticancer Res; 1999; 19(1A):291-9. PubMed ID: 10226557
[TBL] [Abstract][Full Text] [Related]
37. Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells.
Liu XM; Jiang JD; Ferrari AC; Budman DR; Wang LG
Br J Cancer; 2003 Oct; 89(8):1566-73. PubMed ID: 14562033
[TBL] [Abstract][Full Text] [Related]
38. Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells.
Chiu WH; Luo SJ; Chen CL; Cheng JH; Hsieh CY; Wang CY; Huang WC; Su WC; Lin CF
Biochem Pharmacol; 2012 May; 83(9):1159-71. PubMed ID: 22285910
[TBL] [Abstract][Full Text] [Related]
39. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.
Simoens C; Lardon F; Pauwels B; De Pooter CM; Lambrechts HA; Pattyn GG; Breillout F; Vermorken JB
BMC Cancer; 2008 Feb; 8():65. PubMed ID: 18312675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
